arrow
X

Xufen Zheng

edigene inc.
H指数:7
被引数:205

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Glycan shielding enables TCR-sufficient allogeneic CAR-T therapy

糖链屏蔽使TCR足够的同种异体CAR-T疗法成为可能

Cell
IF42.5
2025-08-210
OAAI
Changes in Glycosylation on the Cell Surface Result in Highly Potent and Long-Lasting Allogeneic CAR-T Therapy in Patients

细胞表面糖基化变化导致同种异体CAR-T疗法在患者中具有高度有效且持久的效果

BLOOD
IF23.1
2024-11-050
PRE
Genomic and transcriptomic landscape of human gastrointestinal stromal tumors
2024-11-030
OAAI
Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma

全基因组CRISPR筛选鉴定PKMYT1作为胰腺导管腺癌的治疗靶点

2024-04-030
OAAI
E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer
2021-06-1832
OAAI